Characteristics | Patients in Original Trial N = 431 | Patients Available for Follow-up n = 379 | Patients Lost to Follow-up n = 52 | P Valuea |
---|---|---|---|---|
Women, No. (%) | 265 (61.5) | 235 (62.0) | 30 (57.7) | .55 |
Age, mean (SD), y | 49.9 (15.3) | 49.9 (15.0) | 49.8 (17.6) | .93 |
Comorbidity at index visit, No. (%) | ||||
COPD | 31 (7.2) | 24 (6.3) | 7 (13.5) | .06 |
Asthma | 39 (9) | 31 (8.2) | 8 (15.4) | .09 |
Antibiotics prescribed, No. (%) | ||||
At index visit of trial | 178 (41.3) | 160 (42.2) | 18 (34.6) | .30 |
During 28-day follow-up of trial | 221 (51.3) | 197 (52.0) | 24 (46.2) | .43 |
Note: data in this table represent information recorded during the index visit and 28-day follow-up of the original trial.
COPD = chronic obstructive pulmonary disease.
↵a P values come from Mann-Whitney test (age) or χ2 test (other variables) comparing those available for follow-up with those lost to follow-up.